Pitié-Salpêtrière University Hospital is a teaching hospital in the 13th arrondissement of Paris. Part of the Assistance Publique – Hôpitaux de Paris and a teaching hospital of Sorbonne University, it is one of Europe's largest hospitals. It is also France's largest hospital.

During the past decade, Groupe Hospitalier Pitie-Salpetriere - Centre d'Investigation Clinique Neurosciences 1422 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Groupe Hospitalier Pitie-Salpetriere - Centre d'Investigation Clinique Neurosciences 1422" are "Amyotrophic Lateral Sclerosis" (2 trials). Many other conditions were trialed in "Groupe Hospitalier Pitie-Salpetriere - Centre d'Investigation Clinique Neurosciences 1422" in a lesser frequency.

Most popular intervention types in "Groupe Hospitalier Pitie-Salpetriere - Centre d'Investigation Clinique Neurosciences 1422" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Arimoclomol" (2 trials) and "Placebo oral capsule" (1 trials). Other intervention names were less common.

The vast majority of trials in "Groupe Hospitalier Pitie-Salpetriere - Centre d'Investigation Clinique Neurosciences 1422" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Groupe Hospitalier Pitie-Salpetriere - Centre d'Investigation Clinique Neurosciences 1422". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Groupe Hospitalier Pitie-Salpetriere - Centre d'Investigation Clinique Neurosciences 1422, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Groupe Hospitalier Pitie-Salpetriere - Centre d'Investigation Clinique Neurosciences 1422, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".